Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

MADRIGAL PHARMACEUTICALS, INC.

Filed by MADRIGAL PHARMACEUTICALS, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-16 06:26:08 UTC.

Source-reported fields

Filing overview

Type
Registration
Posted
Oct 7, 2025
Income
Not reported
Expenses
Not reported
Filing UUID
4085ba16-2bc5-4594-9f54-2563a5bcf711
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

MED · Medical/Disease Research/Clinical Labs

FDA and regulatory issues related to the biopharmaceutical industry

MMM · Medicare/Medicaid

FDA and regulatory issues related to the biopharmaceutical industry

INS · Insurance

FDA and regulatory issues related to the biopharmaceutical industry

TAR · Tariff (miscellaneous tariff bills)

FDA and regulatory issues related to the biopharmaceutical industry

HCR · Health Issues

FDA and regulatory issues related to the biopharmaceutical industry

TRD · Trade (domestic/foreign)

FDA and regulatory issues related to the biopharmaceutical industry

SCI · Science/Technology

FDA and regulatory issues related to the biopharmaceutical industry

PHA · Pharmacy

FDA and regulatory issues related to the biopharmaceutical industry

CPT · Copyright/Patent/Trademark

FDA and regulatory issues related to the biopharmaceutical industry

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.